61 related articles for article (PubMed ID: 38292656)
1. TRIM45 facilitates NASH-progressed HCC by promoting fatty acid synthesis via catalyzing FABP5 ubiquitylation.
Li X; He W; Chen X; Zhang Y; Zhang J; Liu F; Li J; Zhao D; Xia P; Ma W; Wu T; Wang H; Yuan Y
Oncogene; 2024 May; ():. PubMed ID: 38755308
[TBL] [Abstract][Full Text] [Related]
2. Fatty acid binding protein 5 suppression attenuates obesity-induced hepatocellular carcinoma by promoting ferroptosis and intratumoral immune rewiring.
Sun J; Esplugues E; Bort A; Cardelo MP; Ruz-Maldonado I; Fernández-Tussy P; Wong C; Wang H; Ojima I; Kaczocha M; Perry R; Suárez Y; Fernández-Hernando C
Nat Metab; 2024 Apr; 6(4):741-763. PubMed ID: 38664583
[TBL] [Abstract][Full Text] [Related]
3. Expression Profiles and Prognostic Value of FABPs in Colorectal Adenocarcinomas.
Prayugo FB; Kao TJ; Anuraga G; Ta HDK; Chuang JY; Lin LC; Wu YF; Wang CY; Lee KH
Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680577
[TBL] [Abstract][Full Text] [Related]
4. High Ki67 Gene Expression Is Associated With Aggressive Phenotype in Hepatocellular Carcinoma.
Ramos-Santillan V; Oshi M; Nelson E; Endo I; Takabe K
World J Oncol; 2024 Apr; 15(2):257-267. PubMed ID: 38545476
[TBL] [Abstract][Full Text] [Related]
5. The role of fatty acid-binding protein 5 and 7 on locomotor, anxiety and social behavior: Interaction with NMDA signaling.
Khan A; Richardson B; Roeder N; Hamilton J; Marion M; Fearby N; White O; Owada Y; Kagawa Y; Thanos PK
Neurosci Lett; 2024 Jun; 836():137862. PubMed ID: 38851448
[TBL] [Abstract][Full Text] [Related]
6. Spinster Homologue 2 Expression Correlates With Improved Patient Survival in Hepatocellular Carcinoma Despite Association With Lymph-Angiogenesis.
Sarkar J; Oshi M; Satyananda V; Chida K; Yan L; Maiti A; Hait N; Endo I; Takabe K
World J Oncol; 2024 Apr; 15(2):181-191. PubMed ID: 38545475
[TBL] [Abstract][Full Text] [Related]
7. Low adipocyte hepatocellular carcinoma is associated with aggressive cancer biology and with worse survival.
Mukhopadhyay S; Tokumaru Y; Oshi M; Endo I; Yoshida K; Takabe K
Am J Cancer Res; 2022; 12(8):4028-4039. PubMed ID: 36119828
[TBL] [Abstract][Full Text] [Related]
8. Fatty Acid Binding to the Human Transport Proteins FABP3, FABP4, and FABP5 from a Ligand's Perspective.
Michler S; Schöffmann FA; Robaa D; Volmer J; Hinderberger D
J Biol Chem; 2024 May; ():107396. PubMed ID: 38777142
[TBL] [Abstract][Full Text] [Related]
9. Characterization of tumor evolution by functional clonality and phylogenetics in hepatocellular carcinoma.
Kacar Z; Slud E; Levy D; Candia J; Budhu A; Forgues M; Wu X; Raziuddin A; Tran B; Shetty J; Pomyen Y; Chaisaingmongkol J; Rabibhadana S; Pupacdi B; Bhudhisawasdi V; Lertprasertsuke N; Auewarakul C; Sangrajrang S; Mahidol C; Ruchirawat M; Wang XW
Commun Biol; 2024 Mar; 7(1):383. PubMed ID: 38553628
[TBL] [Abstract][Full Text] [Related]
10. Midnolin Regulates Liver Cancer Cell Growth In Vitro and In Vivo.
Kweon SM; Kim G; Jeong Y; Huang W; Lee JS; Lai KKY
Cancers (Basel); 2022 Mar; 14(6):. PubMed ID: 35326575
[TBL] [Abstract][Full Text] [Related]
11. Identification and targeting of metastatic biomarkers for hepatocellular carcinoma therapeutics using small molecules library of curcumin analogues.
Gupta A; Choudhary P; Singh S
Mol Divers; 2024 Apr; ():. PubMed ID: 38689175
[TBL] [Abstract][Full Text] [Related]
12. Targeting the fatty acid binding proteins disrupts multiple myeloma cell cycle progression and MYC signaling.
Farrell M; Fairfield H; Karam M; D'Amico A; Murphy CS; Falank C; Pistofidi RS; Cao A; Marinac CR; Dragon JA; McGuinness L; Gartner CG; Iorio RD; Jachimowicz E; DeMambro V; Vary C; Reagan MR
Elife; 2023 Mar; 12():. PubMed ID: 36880649
[TBL] [Abstract][Full Text] [Related]
13. [Study of abnormal lipid metabolism analysis and significance of fatty acid binding protein expression in patients with hepatocellular carcinoma].
Lin YX; Chen K; An FM; Wang YF; Wu XB; Zhan Q; Zhang GQ
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):1006-1013. PubMed ID: 34814397
[No Abstract] [Full Text] [Related]
14. Fatty acid binding protein 5 promotes tumor angiogenesis and activates the IL6/STAT3/VEGFA pathway in hepatocellular carcinoma.
Pan L; Xiao H; Liao R; Chen Q; Peng C; Zhang Y; Mu T; Wu Z
Biomed Pharmacother; 2018 Oct; 106():68-76. PubMed ID: 29957468
[TBL] [Abstract][Full Text] [Related]
15. FABP5 as a novel molecular target in prostate cancer.
O'Sullivan SE; Kaczocha M
Drug Discov Today; 2020 Sep; ():. PubMed ID: 32966866
[TBL] [Abstract][Full Text] [Related]
16. The emerging role of fatty acid binding protein 5 (FABP5) in cancers.
George Warren W; Osborn M; Yates A; Wright K; O'Sullivan SE
Drug Discov Today; 2023 Jul; 28(7):103628. PubMed ID: 37230284
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid binding protein 5 is a novel therapeutic target for hepatocellular carcinoma.
Li Y; Lee W; Zhao ZG; Liu Y; Cui H; Wang HY
World J Clin Oncol; 2024 Jan; 15(1):130-144. PubMed ID: 38292656
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
